Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CURO
8826
CALL
DELISTED
CURO Group Holdings Corp.
CURO
| $321K | ﹤0.01% |
22,400
+9,000
| +67% | +$82.8K |
|
8827
Anavex Life Sciences
AVXL
$298M
| $320K | ﹤0.01% |
59,384
-8,803
| -13% | -$46.4K |
|
8828
PUT
Xcel Energy
XEL
$49.5B
| $320K | ﹤0.01% |
4,800
-6,700
| -58% | -$467K |
|
|
SYRS
8829
CALL
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $320K | ﹤0.01% |
+2,950
| New | +$269K |
|
|
CYBE
8830
DELISTED
Cyberoptics Corp
CYBE
| $320K | ﹤0.01% |
+14,108
| New | +$401K |
|
8831
VirnetX Holding Corp
VHC
$62.8M
| $319K | ﹤0.01% |
3,167
-3,501
| -53% | -$378K |
|
|
AY
8832
CALL
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $319K | ﹤0.01% |
8,400
-16,200
| -66% | -$536K |
|
|
FRGI
8833
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $319K | ﹤0.01% |
27,990
+11,365
| +68% | +$125K |
|
8834
PUT
GFL Environmental
GFL
$15.1B
| $318K | ﹤0.01% |
+10,900
| New | +$267K |
|
8835
ARK Israel Innovative Technology ETF
IZRL
$141M
| $318K | ﹤0.01% |
+10,717
| New | +$290K |
|
8836
Mueller Industries
MLI
$14.6B
| $318K | ﹤0.01% |
36,188
-310,236
| -90% | -$2.48M |
|
8837
Metallus
MTUS
$904M
| $318K | ﹤0.01% |
68,108
-14,718
| -18% | -$66.6K |
|
8838
CALL
Arch Capital
ACGL
$33.7B
| $317K | ﹤0.01% |
8,800
-16,700
| -65% | -$548K |
|
8839
PUT
Archrock
AROC
$6.08B
| $317K | ﹤0.01% |
36,600
+11,000
| +43% | +$80.3K |
|
|
AVNS
8840
CALL
DELISTED
Avanos Medical
AVNS
| $317K | ﹤0.01% |
6,900
-700
| -9% | -$29.1K |
|
8841
CALL
UFP Industries
UFPI
$4.96B
| $317K | ﹤0.01% |
5,700
-900
| -14% | -$49.4K |
|
8842
PUT
Viavi Solutions
VIAV
$10.7B
| $317K | ﹤0.01% |
21,200
-9,500
| -31% | -$126K |
|
|
CNST
8843
PUT
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $317K | ﹤0.01% |
+11,000
| New | +$277K |
|
|
AGEN
8844
Agenus
AGEN
$329M
| $316K | ﹤0.01% |
5,065
-9,038
| -64% | -$671K |
|
8845
PUT
Avnet
AVT
$7.86B
| $316K | ﹤0.01% |
9,000
-5,400
| -38% | -$160K |
|
|
8846
PUT
Anavex Life Sciences
AVXL
$298M
| $316K | ﹤0.01% |
58,600
+38,800
| +196% | +$204K |
|
8847
PUT
BlueLinx
BXC
$680M
| $316K | ﹤0.01% |
10,800
-4,300
| -28% | -$110K |
|
|
GNTY
8848
DELISTED
Guaranty Bancshares
GNTY
| $316K | ﹤0.01% |
+11,623
| New | +$308K |
|
8849
PUT
Mustang Bio
MBIO
$4.5M
| $316K | ﹤0.01% |
111
+4
| +4% | +$9.56K |
|
8850
Nuveen ESG Large-Cap Value ETF
NULV
$2.29B
| $316K | ﹤0.01% |
+9,590
| New | +$300K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.